Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Salah S. Alshagrawi. (2023) Examining health sciences students’ intention to uptake COVID-19 vaccination using the theory of planned behavior. Human Vaccines & Immunotherapeutics 19:2.
Read now
Read now
Guillermo M. Ruiz-Palacios, John H. Beigel, Maria Lourdes Guerrero, Lucile Bellier, Ramiro Tamayo, Patricia Cervantes, Fabián P. Alvarez, Arturo Galindo-Fraga, Felipe Aguilar-Ituarte & Juan Guillermo Lopez. (2020) Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico. Human Vaccines & Immunotherapeutics 16:4, pages 827-835.
Read now
Read now
Riju Ray, Gaël Dos Santos, Philip O. Buck, Carine Claeys, Gonçalo Matias, Bruce L. Innis & Rafik Bekkat-Berkani. (2017) A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control. Human Vaccines & Immunotherapeutics 13:7, pages 1640-1652.
Read now
Read now
Pieter T. de Boer, Britt M. van Maanen, Oliver Damm, Bernhard Ultsch, Franklin C.K. Dolk, Pascal Crépey, Richard Pitman, Jan C. Wilschut & Maarten J. Postma. (2017) A systematic review of the health economic consequences of quadrivalent influenza vaccination. Expert Review of Pharmacoeconomics & Outcomes Research 17:3, pages 249-265.
Read now
Read now
Mathieu Uhart, Hélène Bricout, Emilie Clay & Nathalie Largeron. (2016) Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe. Human Vaccines & Immunotherapeutics 12:9, pages 2259-2268.
Read now
Read now
Articles from other publishers (8)
Clara R. Warmath, Ismael R. Ortega-Sanchez, Lindsey M. Duca, Rachael M. Porter, Molly G. Usher, Joseph S. Bresee, Kathryn E. Lafond & William W. Davis. (2023) Comparisons in the Health and Economic Assessments of Using Quadrivalent Versus Trivalent Influenza Vaccines: A Systematic Literature Review. Value in Health 26:5, pages 768-779.
Crossref
Crossref
Irina Kiseleva. (2019) Will We Ever be Able to Defeat Human Influenza?. The Open Microbiology Journal 13:1, pages 313-314.
Crossref
Crossref
Dabeyva Chavez, Vicente Gonzales‐Armayo, Elvis Mendoza, Rakhee Palekar, Rosario Rivera, Angel Rodriguez, Claudia Salazar, Angel Veizaga & Arletta Añez. (2019) Estimation of influenza and respiratory syncytial virus hospitalizations using sentinel surveillance data—La Paz, Bolivia. 2012–2017. Influenza and Other Respiratory Viruses 13:5, pages 477-483.
Crossref
Crossref
Larisa Rudenko, Irina Kiseleva, Elena Krutikova, Ekaterina Stepanova, Andrey Rekstin, Svetlana Donina, Maria Pisareva, Elena Grigorieva, Kirill Kryshen, Arman Muzhikyan, Marina Makarova, Erin Grace Sparrow, Guido Torelli & Marie-Paule Kieny. (2018) Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model. PLOS ONE 13:12, pages e0208028.
Crossref
Crossref
Yun-Kyung Kim, Joon Young Song, Hyeongap Jang, Tae Hyun Kim, Heejo Koo, Lijoy Varghese & Euna Han. (2018) Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea. PharmacoEconomics 36:12, pages 1475-1490.
Crossref
Crossref
José Antonio López Trigo, Rosa López Mongil, Alberto Mariano Lázaro, Gloria Mato Chaín, Norberto Moreno Villajos & Primitivo Ramos Cordero. (2018) Vacunación frente a la gripe estacional en las personas mayores. Evaluación de la vacuna tetravalente. Informe de posicionamiento. Revista Española de Geriatría y Gerontología 53, pages 185-202.
Crossref
Crossref
Viviana Sotomayor, Rodrigo A. Fasce, Natalia Vergara, Felipe De la Fuente, Sergio Loayza & Rakhee Palekar. (2018) Estimating the burden of influenza-associated hospitalizations and deaths in Chile during 2012-2014. Influenza and Other Respiratory Viruses 12:1, pages 138-145.
Crossref
Crossref
George J. Milne, Nilimesh Halder, Joel K. Kelso, Ian G. Barr, Jocelyn Moyes, Kathleen Kahn, Rhian Twine & Cheryl Cohen. (2016) Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study. Influenza and Other Respiratory Viruses 10:4, pages 324-332.
Crossref
Crossref